TG Therapeutics Inc. (TGTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    TG Therapeutics Inc.

    NASDAQ: TGTX · Real-Time Price · USD
    32.00
    -0.38 (-1.17%)
    At close: Sep 09, 2025, 3:59 PM
    31.81
    -0.59%
    After-hours: Sep 09, 2025, 07:56 PM EDT

    TG Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 329M 233.66M 2.79M 6.69M
    Cost of Revenue
    		 38.49M 14.13M 265K 790K
    Gross Profit
    		 290.52M 219.53M 2.52M 5.9M
    Operating Income
    		 41.93M 20.63M -192.84M -344.77M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 25.59M 13.06M -198.34M -348.1M
    Net Income
    		 23.38M 12.67M -203.83M -355.55M
    Selling & General & Admin
    		 154.3M 122.71M 83.23M 152.14M
    Research & Development
    		 94.29M 76.19M 112.13M 198.53M
    Other Expenses
    		 n/a n/a n/a 2.31M
    Operating Expenses
    		 248.59M 198.9M 195.36M 350.67M
    Interest Expense
    		 24.03M 12.62M 10.19M 5.64M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 287.07M 213.03M 195.62M 351.46M
    Income Tax Expense
    		 2.21M 390K 5.5M 7.45M
    Shares Outstanding (Basic)
    		 145.32M 141.96M 135.41M 132.22M
    Shares Outstanding (Diluted)
    		 160.34M 148.51M 135.41M 132.22M
    EPS (Basic)
    		 0.16 0.09 -1.51 -2.69
    EPS (Diluted)
    		 0.15 0.09 -1.51 -2.69
    EBITDA
    		 49.9M 26.1M -187.63M -341.97M
    EBIT
    		 49.62M 25.68M -188.14M -342.46M
    Depreciation & Amortization
    		 280K 423K 515K 494K

    Add to Watchlist